RESUMEN
BACKGROUND: Angiotensin-converting enzyme (ACE) 2 is known to be a functional receptor for SARS-CoV-2 in the current pandemic. Soluble ACE2 (sACE2) concentrations are elevated in patients with various cardiovascular disorders including heart failure. METHODS: In a total of 182 consecutive adult patients with complex congenital heart disease (CHD) and 63 healthy controls, sACE2 concentrations were measured in serum using the Human ACE2® assay by Cloud-Clone Corporation and associated with clinical, laboratory and echocardiographic parameters. RESULTS: Median sACE2 levels were increased in patients with complex CHD as compared to healthy controls (761.9 pg/ml vs 365.2 pg/ml, p < 0.001). Moreover, sACE2 concentrations were significantly elevated in patients with a higher NYHA class ≥ III (1856.2 pg/ml vs 714.5 pg/ml in patients with NYHA class I/II, p < 0.001). Using linear regression analysis, higher sACE2 levels were associated with a higher NYHA class ≥ III, more severe CHD, a morphological left systemic ventricle, higher creatinine and the use of mineralocorticoid receptor antagonists (MRA) in the univariable model. The use of ACE inhibitors or angiotensin receptor blockers (ARB) was associated with lower sACE2 levels. In the multivariable model, higher sACE2 levels were independently associated with a higher NYHA class ≥ III (p = 0.002) and lower sACE2 levels with the use of ACE inhibitors or ARB (p = 0.001). CONCLUSION: Soluble ACE2 concentrations were significantly increased in all types of complex CHD with highest levels found in patients with NYHA class ≥ III. Moreover, a higher NYHA class ≥ III was the most significant determinant that was independently associated with elevated sACE2 concentrations.
Asunto(s)
Enzima Convertidora de Angiotensina 2/sangre , Cardiopatías Congénitas/enzimología , Receptores Virales/sangre , Sobrevivientes , Adulto , Biomarcadores/sangre , COVID-19/enzimología , COVID-19/virología , Estudios de Casos y Controles , Femenino , Cardiopatías Congénitas/sangre , Cardiopatías Congénitas/diagnóstico , Humanos , Masculino , SARS-CoV-2/metabolismo , SARS-CoV-2/patogenicidad , Regulación hacia Arriba , Internalización del Virus , Adulto JovenRESUMEN
There is an urgent need to understand the underlying mechanisms contributing to thrombotic and inflammatory complications during COVID-19. Data from independent groups have identified that platelets are hyperreactive during COVID-19. Platelet hyperreactivity is accompanied by changes in platelet gene expression, and enhanced interactions between platelets and leukocytes. In some patients, SARS-CoV-2 mRNA has been detected in platelets. Together, this suggests that SARS-CoV-2 may interact with platelets. However, controversy remains on which receptors mediate SARS-CoV-2 platelet interactions. Most, but not all, transcriptomic and proteomic analyses fail to observe the putative SARS-CoV-2 receptor, angiotensin converting enzyme-2, or the cellular serine protease necessary for viral entry, TMPRSS2, on platelets and megakaryocytes. Interestingly, platelets express other known SARS-CoV-2 receptors, which induce similar patterns of activation to those observed when platelets are incubated with SARS-CoV-2. This article explores these findings and discusses ongoing areas of controversy and uncertainty with regard to SARS-CoV-2 platelet interactions.
Asunto(s)
Enzima Convertidora de Angiotensina 2/sangre , Plaquetas/virología , COVID-19/sangre , COVID-19/virología , Receptores Virales/sangre , SARS-CoV-2/fisiología , SARS-CoV-2/patogenicidad , Enzima Convertidora de Angiotensina 2/fisiología , COVID-19/complicaciones , Interacciones Microbiota-Huesped/genética , Interacciones Microbiota-Huesped/fisiología , Humanos , Megacariocitos/virología , Modelos Biológicos , Activación Plaquetaria , ARN Viral/sangre , ARN Viral/genética , Receptores Virales/fisiología , SARS-CoV-2/genética , Serina Endopeptidasas/sangre , Serina Endopeptidasas/fisiología , Trombosis/sangre , Trombosis/etiología , Trombosis/virología , Internalización del VirusAsunto(s)
Betacoronavirus , Cromosomas Humanos Par 12/genética , Cromosomas Humanos Par 21/genética , Cromosomas Humanos X/genética , Infecciones por Coronavirus/genética , Regulación Enzimológica de la Expresión Génica/genética , Peptidil-Dipeptidasa A/sangre , Neumonía Viral/genética , Polimorfismo de Nucleótido Simple , Receptores Virales/sangre , Caracteres Sexuales , Anciano , Anciano de 80 o más Años , Alelos , Enzima Convertidora de Angiotensina 2 , COVID-19 , Infecciones por Coronavirus/sangre , Infecciones por Coronavirus/enzimología , Infecciones por Coronavirus/epidemiología , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Genotipo , Factor Nuclear 1-alfa del Hepatocito/genética , Humanos , Mutación INDEL , Desequilibrio de Ligamiento , Masculino , Persona de Mediana Edad , Pandemias , Peptidil-Dipeptidasa A/biosíntesis , Peptidil-Dipeptidasa A/genética , Neumonía Viral/sangre , Neumonía Viral/enzimología , Neumonía Viral/epidemiología , Receptores Virales/biosíntesis , Receptores Virales/genética , Riesgo , SARS-CoV-2 , Distribución por Sexo , Regulador Transcripcional ERG/genéticaRESUMEN
BACKGROUND: Since its discovery in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 2 180 000 people worldwide and has caused more than 150 000 deaths as of April 16, 2020. SARS-CoV-2, which is the virus causing coronavirus disease 2019 (COVID-19), uses the angiotensin-converting enzyme 2 (ACE2) as a cell receptor to invade human cells. Thus, ACE2 is the key to understanding the mechanism of SARS-CoV-2 infection. This study is to investigate the ACE2 expression in various human tissues in order to provide insights into the mechanism of SARS-CoV-2 infection. METHODS: We compared ACE2 expression levels across 31 normal human tissues between males and females and between younger (ages ≤ 49 years) and older (ages > 49 years) persons using two-sided Student's t test. We also investigated the correlations between ACE2 expression and immune signatures in various tissues using Pearson's correlation test. RESULTS: ACE2 expression levels were the highest in the small intestine, testis, kidneys, heart, thyroid, and adipose tissue, and were the lowest in the blood, spleen, bone marrow, brain, blood vessels, and muscle. ACE2 showed medium expression levels in the lungs, colon, liver, bladder, and adrenal gland. ACE2 was not differentially expressed between males and females or between younger and older persons in any tissue. In the skin, digestive system, brain, and blood vessels, ACE2 expression levels were positively associated with immune signatures in both males and females. In the thyroid and lungs, ACE2 expression levels were positively and negatively associated with immune signatures in males and females, respectively, and in the lungs they had a positive and a negative correlation in the older and younger groups, respectively. CONCLUSIONS: Our data indicate that SARS-CoV-2 may infect other tissues aside from the lungs and infect persons with different sexes, ages, and races equally. The different host immune responses to SARS-CoV-2 infection may partially explain why males and females, young and old persons infected with this virus have markedly distinct disease severity. This study provides new insights into the role of ACE2 in the SARS-CoV-2 pandemic.